Sunday, August 11, 2013

Stamp The Foreheads of People With Alzheimer's

Do I really want my wife and others with Alzheimer’s Disease (AD) to walk around with their foreheads stamped?  Of course not.  But, I must confess, there are times when I do wish that such a stamp existed.  The imprint would be, “"I have Alzheimer’s  ... please speak to my caregiver, not to me.”" 

We need to better sensitize everyone in the medical field to the realities of Alzheimer’s.  People with Alzheimer’s cannot be expected to understand or remember what is asked of them, what is said to them, what is done to them, or what they have just been told to do.  That is why everyone in the medical profession must always remember to speak directly with the caregivers of their AD patients.  Receptionists at medical facilities and in doctors’offices, lab technicians, rehabilitation workers, therapists, health care aides, nurses, physician assistants, dentists, dental hygienists … and, sadly on occasion, even some doctors … need to always be aware that they should never discuss important information with AD patients when their caregivers are not present.  AD patients are often unable to correctly hear, remember, process, or share important information with their caregivers.  Remember that stamp!

Caregivers should either be present with AD patients when they are being examined, or should be present whenever any discussion of that examination takes place.  Medical personnel should never ask AD patients for important information about current medications or medical issues during examinations when caregivers are not present.  Remember that stamp!

Medical personnel must also be sensitized to the futility of communicating with most AD patients by telephone.  Telephone messages should never be left with an AD patient.  AD patients will often either not remember receiving such calls, or not process that information, or forget to share that information with their caregiver.  As an AD spouse caregiver, I’ve had to call back medical offices to indicate that my spouse remembered receiving a telephone message, but didn’t remember what was said.  I’ve also had to call back to say that my spouse relayed a telephone message to me that I knew could not possibly be accurate.  Members of my weekly AD spouse support group report similar incidents.  Were important information communicated directly to caregivers, these frustrations and misunderstandings could be easily avoided.  Remember that stamp!

The medical profession is guided by ethical standards and legal guidelines to legitimately protect the privacy rights of their patients.  However, HIPAA Privacy Rule regulations do allow doctors and medical professionals to exercise reasonable judgment in determining what information may be shared with relatives and friends of patients.  In my particular situation, for example, my wife cannot be expected to give anyone accurate information about anything anymore … not about her medical history, not about her medications, not about her current symptoms, and not about her 6 ADLs (Activities of Daily Living).  I must be present to answer such questions and provide such information.  Similarly, my wife cannot be expected to remember information she is given nor can she be expected to share that information accurately with me.  If AD patients are in early or moderate stages of Alzheimer’s, they can probably provide specific permission for doctors to share all medical information with their caregivers.  But if AD patients are unable to communicate such permission, and doctors and medical personnel feel uncomfortable about sharing all medical information with caregivers, they can simply ask caregivers to provide them with copies of their durable power of attorney to authorize such communication.  Remember that stamp!

Let’s stop expecting AD patients to provide accurate information about themselves or their medical condition.  Always speak directly with their caregivers if you want to obtain such information.  And let’s stop communicating important test results or any other relevant medical information solely to AD patients.  Either speak with your AD patients only when their caregivers are present, or just communicate directly with their caregivers.  Remember that stamp!
 
Published in Journal of the American Geriatrics Society,  August, 2012.  Vol. 60, No. 8, pp. 1597-1598.  Access at:
httm://onlinelibrary.wiley.com/doi/10.1111/j.1532-5415.2012.04084.x/full



 
 
 
 
 
 
 
 

 

Please Tell People with Alzheimer's Not to Drive ... published in reduced version as a Letter to the Editor


Ask any spouse of someone diagnosed with Alzheimer’s Disease (AD) what their toughest battle was, and I guarantee that most, if not all, will say it was about driving.  Taking away the car keys is, by far, the most common cause of conflict … and the most difficult hurdle to overcome … that I hear about in my actual support group and read about in my online support groups.  Why this driving issue causes so much stress and strife is an easy question to answer.  Driving is synonymous with independence … take away the AD patients’ car keys and you are robbing them of their independence to go and come wherever and whenever they want.  Insisting that AD patients stop driving is forcing acceptance of the ramifications of their disease when they may not be in an accepting mode.  Spouses saying “I can still drive” or “I’ll know when I can no longer drive safely” are the two most common refrains I hear in my support groups.  Of course, by definition when one is diagnosed with AD that patient is already suffering from some degree of cognitive, perceptual, and memory impairment that makes driving unsafe.  As the disease progresses, ability to drive safely will only get worse.  There will be impaired judgment and reasoning skills, impaired depth perception, and the inability to interpret the many visual cues and factors affecting one’s ability to drive safely … assessing road conditions, the effects of bad weather, heeding traffic signals, safely turning across oncoming traffic lanes, safe braking distance, etc.

In “Alzheimer’s: When to stop driving,” Mayo Clinic staff summarize the risks of driving with an AD diagnosis.  To answer the question of when the AD patient should stop driving, they provide this advice: “Ask yourself whether you’d feel safe riding in a vehicle driven by the person who has Alzheimer’s – or if you’d feel safe having your loved one drive your children or others.  If the answer is no, then you know it’s time for him or her to retire from driving.”  1.  

Whereas I concur completely with this advice, this does not solve the problem of getting the AD patient to actually “retire” from driving when driving is unsafe.  All too often, the AD patient will continue to insist that he or she can continue to drive safely despite what the caregiver or other loved ones say.  Sometimes, only a doctor will be able to convince a patient that it is time to stop driving.  Yet, too often doctors shy away from this responsibility.  And, sadly, doctors even have support for such a position from two highly respected organizations.

The American Academy of Neurology (AAN), states that the decision of whether or not to continue driving should be left to the patient in consultation with the doctor.  The AAN guideline issued in 2000 stated that patients should stop driving after a dementia diagnosis.  But the revised 2010 AAN guideline backs away from that categorical position.  Noting that “giving up driving is associated with depression and increased awareness of mortality,” the new guideline calls for doctors to implement the Clinicla Dementia Rating Scale to help determine when dementia patients should stop driving.  According to the guideline, this scale, which allows for input from the patient and caregiver, should help the doctor make a more informed decision of when to advise a patient to stop driving.  2.  

Similarly, the Alzheimer’s Association (AA) website has several pages that discuss when it is time for a person with AD to stop driving.  ”A diagnosis of Alzheimer’s is not a reason to take away driving privileges,” according to their Safety Center page.  3.   The AA website also provides a lengthy “Driving Assessment” position from their Georgia chapter that indicates that there should be an on-the-road driving assessment, or a test by an occupational therapist, to help determine when the AD patient should stop driving.  Noting warning signs and risk factors similar to those in the AAN guideline and on the Mayo Clinic website, the AA suggests that those risk factors should determine when it is time to stop driving.  4.

I find both the AAN and AA positions very troubling.  While it is true that  people with mild dementia may still be able to drive safely for a period of time, no one … no doctor, no occupational therapist, and certainly no patient or caregiver … can determine the exact time when that AD patient will no longer be able to drive safely.  Must we wait until a preventable tragedy occurs until those keys are taken away?  If everyone agrees that the AD patient’s skills and abilities are going to decline to make driving unsafe, why wait until that decline causes injury or death to the patient or innocent others?

In my opinion, a dementia or AD diagnosis should automatically mandate removal of a driver's license … if not immediately, then certainly within a period 3 to 6 months, at most.  Anyone diagnosed with AD already has, or will soon have, judgment and reasoning skills that are too impaired to continue to drive safely.  Once a person’s cognitive skills become impaired to the point of a doctor diagnosing probable Alzheimer’s, how can one reasonably argue that driving is still a safe activity for that person?  A car can be thought of as a weapon of limited destruction if an AD-impaired driver should injure or kill another driver or vehicle passenger, or an innocent pedestrian.  A car can also be considered a weapon of mass destruction if an AD-impaired driver crashes into a group of pedestrians, or crashes through a storefront window, or causes an accident with a fully loaded vehicle or bus that leads to multiple injuries or deaths.  The AAN had it right in 2000 … a dementia diagnosis should signal an end to safe driving.  Period!

In a handful of states, physicians are required to report names of patients diagnosed with Alzheimer’s to the Department of Motor Vehicles (DMV). The DMV is then responsible for determining whether that person should continue driving or not. But the DMV and doctors already know that, on any given day, a person with AD may be able to do well on a written test or even on a road evaluation … such is the nature of AD.  Just as an AD patient can score well on an MMSE given at noon but by 3 p.m. not even remember having taken that test, so can an AD patient fool a DMV examiner into thinking he or she can drive safely. 

Doctors should know better than to let such an important decision hinge upon a patient’s performance at one given time.  Doctors should know that multiple decisions and processing skills are needed each time someone gets behind the wheel of a car, and that AD-impaired drivers will have difficulty processing the information requiring them to driver safely.  If we know with certitude that a person diagnosed with AD is going to experience cognitive decline over time, why not stop that person from driving before a tragedy occurs?  Those 2010 AAN guidelines state that “a recent history of collisions or moving violations,” among other signs, “may indicate increased risk for driving.”  May indicate?  Must we wait until after a tragedy occurs before taking the keys away from an AD patient?

I think there really is only one indicator of when a person with AD should stop driving … and that is the AD diagnosis itself.  If someone has AD, that person should not be behind the wheel of a car.  In my AD spouse caregiver support group, we always ask this question of new members facing the driving issue, akin to the Mayo Clinic advice:  "Would you feel comfortable with your grandchildren in the car while your AD spouse is driving?"  Invariably, the answer from the spouse caregiver is no, but usually the spouse caregiver then relates something like this: “I agree with you but I just cannot get my spouse to give me the keys.  My spouse says, But the doctor never said that I had to stop driving, so it can’t be that serious; If I shouldn’t be driving anymore, the doctor would have said something to me.”

So I am saying this to all doctors treating patients for any kind of dementia, but especially for Alzheimer’s Disease:  Please, doctors … at the time of diagnosis or very shortly thereafter, please assume responsibility for telling your patients that they must stop driving.  Spouses and caregivers should not have to deal with this highly emotional decision without your help.  Yes, taking away the car keys also takes away independence from your patients.  And yes, taking away the car keys may even lead to depression in some of your patients.  And yes, some of your newly diagnosed patients could probably continue driving safely for quite some time.  But, you know that it is just a matter of time before your newly diagnosed patient loses the cognitive ability to drive safely … if that has not already happened … and your patient may not be scheduled to even see you again before this happens.  So, why wait until after a preventable tragedy occurs?  Let me put it one more way:  Imagine the lawsuit you and your patient could face if the estate of a mortally injured party sues, arguing that the doctor should have know better than to allow a person with diagnosed cognitive deficiencies to continue driving!  So, doctors … please tell Alzheimer’s patients not to drive!

1.  Mayo Clinic staff.  Alzheimers: When to stop driving.  Available at www.mayoclinic.com.  Accessed July 25, 2010.

2. Wesolowski, Kierstin.  New AAN Guideline on Assessing Driving Risk in Dementia Patients.  Neurology Today.  2010; 10 (8): 1, 12.

3. Safety Center.  Available at www.alz.org   Accessed July 25, 2011.

4. Driving Assessment.  Available at www.alz.org.  Accessed July 25, 2011.

Published in Journal of the American Geriatrics Society,  March, 2012, Vol. 60, No. 3, pp. 597-598.  Access at: http://onlinelibrary,wiley.com/doi.10.1111/j.1532-5415.2011.03857.x/full
 
 

Alzheimer's ... Our New Cancer?


A few weeks ago, the Centers for Disease Control reported that “the number of cancer survivors in the United States nearly quadrupled from 1971 to 2007.”  CDC noted that there were 11.7 million cancer survivors during those years due to “earlier detection, improved diagnostic methods, and more effective treatment,” among other reasons.  Much of the credit is due to research funded by the National Institutes of Health over many years.  However, no one diagnosed with Alzheimer’s Disease (AD) has ever been able to report being Alzheimer’s-free.   Furthermore, according to CDC, “about 1.1 million of the (cancer) survivors had lived with the diagnosis for more than 25 years.”  CDC cannot report any AD survivors who have lived for 25 years. There are none.

AD is the sixth leading cause of death in this country, and the only one of the top ten causes of death with no means of prevention or cure.  AD is also the fastest growing cause of death in this country.  More than 5 million Americans have already been diagnosed with AD, and with so many baby boomers turning 65 each day this number is expected to triple over the next 30-40 years. 

Our country faces a huge health crisis with AD that will greatly increase costs to taxpayers in the years ahead. According to Maine Senator Susan Collins, “We spend one penny on research for every dollar the federal government spends on care for patients with Alzheimer’s.  That just doesn’t make any sense.”  Dr. Stanley Prusiner, director of the Institute for Neurodegenerative Diseases at UC, San Francisco, recently stated that “Alzheimer’s is a cancer sized problem requiring a cancer sized solution.  Yet, to date the Alzheimer’s field is grossly underfunded, at a level of less than 10% that of cancer.”  This year, NIH will fund more than $6 billion on cancer research … but less than $500 million for AD research.  NIH will also spend $3 billion on HIV-AIDS research this year, more than six times the money that will be spent on Alzheimer’s research.  Yet, according to a recent issue of Time Magazine, “The numbers of people living with HIV have leveled off while the rates of deaths and new infections have fallen.”  The number of deaths attributable to HIV declined 29% between 2000-2008.  But according to the Alzheimer’s Association’s recent report, “2011 Alzheimer’s Disease Facts and Figures,” during this same time period the number of deaths attributable to AD rose 66%,

Long term care for Alzheimer’s patients already costs this country nearly $200 billion a year.  According to Senator Collins, “If nothing is done to slow or stop the disease, Alzheimer’s will cost the United States $20 trillion over the next 40 years.  The average annual Medicare payment for an individual with Alzheimer’s is three times higher than for those without the condition.”  And according to Dr. Prunsiner, for Medicaid patients, “the costs of an Alzheimer’s beneficiary are nine times that of a non-Alzheimer’s beneficiary.”    

My wife has AD.  Symptoms started appearing at age 59 and she was officially diagnosed at age 63.  No treatment or cure will arrive in time for her.  But if our country begins to devote more funding for AD research as we have for cancer … or even as we have for HIV/AIDS … then perhaps one day people will be able to say that they have lived with this diagnosis for 25 years … and are AD survivors. 
 
Published in Journal of the American Geriatrics Society, December, 2011, Vol. 59, No. 12, pp. 2396-97. Access at: http://onlinelibrary.wiley.com/doi.10.1111/j.1532-5415.2011.03694.x/full
 

 

 

 

 

Clinical Trials ... A Caregiver's Recommendations

My wife recently participated in a major international Phase III clinical trial of a potential new medication for those with early stage Alzheimer’s Disease (AD). Based upon my experience as a spouse/caregiver, I have three recommendations to improve the clinical trial process.
My first recommendation is that clinical trial protocols should allow doctors to inform patients about whether they received medication or a placebo as soon as the patient’s trial participation ends. My wife’s trial lasted one year but she had to wait another year until all participants had completed the trial before learning whether she had received the experimental medication or a placebo. However, my wife also has a serious heart condition and her cardiologist wanted her to begin a new medication. Since this was a double blind trial, not even her AD doctors knew if she had received actual medication or a placebo. If my wife had been receiving the placebo, there would have been no cause for concern. But if she had been receiving the experimental medication, the cardiologist would have preferred a suitable “wash period” before beginning new heart medication. The clinical trial supervisor would not release that information, even though their clinical trial data would be totally unaffected. Protocol directives therefore denied her cardiologist knowledge that led to an unnecessary risk.  Directives not in the patient’s best interests should never be part of any clinical trial protocol. Patients should have the right to learn about the medication or placebo they received as soon as their participation in the trial is over.

My second recommendation is that clinical trial medications/placebos should only come in user-friendly packaging. My wife’s pills came in what is commonly referred to as blister package cards … cards with tiny plastic ‘blister bubbles’ that must be firmly pressed to remove each individual pill. What are the manufacturers thinking? AD patients are mostly elderly, as are their caregivers, and they should not have to experience physical pain and mental stress just to open their pill ‘container’ three times each day! My wife and I found it extremely difficult and time consuming to remove each individual pill. Pharmaceutical companies should be making life easier for patients, not more difficult! All medication for elderly patients in clinical trials should come in easy to open, user-friendly plastic containers!
My final recommendation is that clinical trial protocols for interviewing patients and caregivers need revision. My wife and I were interviewed together at several junctures during the trial. These joint interviews were emotionally difficult for both of us. When asked if my wife had demonstrated a particular AD behavior, if she said no but I said yes it made for a very uncomfortable situation … in the doctor’s office, on the way home, and later that night! (I know of spouses who have knowingly lied at joint interviews simply to maintain marital harmony.) If interviewed jointly, the caregiver should be told that only the patient’s responses are being requested at this time, and that the caregiver will have the opportunity to comment further during a future interview. Especially with diseases such as Alzheimer's, when many patients are in denial about their symptoms … and especially when the caregiver is the patient’s spouse … protocol directives should not place patients and their spouse/caregivers in unnecessary emotionally strained situations. Clinical trial protocols should provide for separate interviews of patients and caregivers to insure an accurate assessment.
Hopefully, one or more of these recommendations will be implemented in a future clinical trial protocol. Participation in clinical trials are, by definition, time-consuming commitments that can, on occasion, be very stressful. There is no need to add unnecessary stress to that experience!
 
Published in Clinical Trials, Journal of the Society of Clinical Trials, October, 2011, Vol. 8, p. 679. Access at:  http://ctj.sagepub.com/content/8/5/679
 

Forget the mental test -- and learn to listen.

My wife, Clare, was diagnosed at age 63 with Alzheimer’s Disease (AD).  Unfortunately, her AD went misdiagnosed for several years despite my repeated attempts both in person and via written logs to convince our doctors ... a primary care physician, neurologist, and clinical psychologist ... that she was experiencing dementia.  Doctors administered the Mini-Mental State Examination, commonly referred to as the MMSE, several times along with other cognitive tests, but Clare initially scored very well on all of her tests.  A brain MRI showed no definitive signs of AD and she was diagnosed and treated first for stress, then anxiety, and then for depression.  However, Clare’s worrisome and now worsening behaviors were among those listed as early AD signs on several reputable websites.  Medications prescribed to treat her diagnosis weren’t working. 

Growing increasing frustrated when told to “stay the course” by the neurologist when I was observing continuing declines firsthand, I convinced Clare to get a second opinion ... this time with a geriatric psychiatrist affiliated with a major medical center who, by the way, requested copies of all of my logs prior to our first visit.  After a lengthy interview, a review of previous tests, discussion of my logs, and comprehensive new cognitive, physical, and neurological testing at this doctor’s AD center, Clare was finally diagnosed with early onset Alzheimer’s. 

I have since discovered, sadly, that many caregivers across the country can tell a very similar story ... reporting observations of AD symptoms that were misdiagnosed by their doctors and initial misdiagnoses based largely upon the MMSE or some other brief cognitive testing instrument.

Most GPs, time pressured on the best of days, are likely to use AD screening tests that can be administered quickly ... and therein lies the problem.  Current popular screening tests for dementia are not particularly effective.  New quick screening tests coming on the market with claims that they can be used effectively to diagnose dementia will most likely be just as ineffective as the MMSE, a cognitive screening test used for more than thirty years.  However, as noted by Dr. Peter V. Rabins, Director of Geriatric Psychiatry and Neuropsychiatry at Johns Hopkins School of Medicine, whereas the MMSE can be sued to screen for cognition disorders, “The MMSE cannot be used to diagnose dementia.”  Dr. Rabins further notes that, “It’s (the MMSE) limitations include its poor ability to detect minor changes in cognition – that is mild dementia – and its lack of testing for certain cognitive functions such as executive function.”  (Johns Hopkins Health Alerts: Memory ... “What is the MMSE?”  December, 2010.)

Researchers at Washington University/St. Louis administered a two minute questionnaire (AD8) to friends or family members (termed “informants”) of patients being screened for dementia and discovered that “informants who have regular exposure to the individual provide the most accurate assessments.”  The study reported that, when comparing the AD8 results to those of the MMSE, the AD8 was found to be “superior to conventional testing in its ability to detect signs of early dementia.”  It can’t tell us whether the dementia is caused by Alzheimer’s or other disorders, but it lets us know when there is a need for more extensive evaluations to answer that question.”  (Galvin JE, Fagan AM, Holtzman DM, et. al, “Relationships of dementia screening tests with biomarkers of Alzheimer’s disease.”  Brain, 2010: 133:3290-3300.)

This study also concluded that the MMSE is not a reliable indicator of AD symptoms because such tests “only give a ‘brief’ snapshot’ of a person’s cognitive abilities at one time ... when they are being tested.”  Any caregiver knows that a person with AD can appear to be fine one moment, but definitely not fine the next moment ... just as my wife scored 29 out of a possible 30 on the MMSE in the doctor’s office on the same day that she forgot how to turn on her computer, and could not locate where we keep milk in our kitchen.

Dr. Ronald Devere, a neurologist who directs an Alzheimer’s Disease and Memory Disorders Center in Austin, Texas noted that there is one major ‘rule of thumb’ that all doctors would follow when trying to diagnose cognitive disorders:  “If a person comes to a doctor with a memory or other cognitive complaints that are verified by caregivers or close friends, a complete battery or neuropsychological testing should be conducted, especially if that person’s score is in normal or mildly cognitively impaired on cognitive testing.  A caregiver or close friend’s observations should always take precedence over office testing of memory and cognitive abilities such as the MMSE.”  (Quoted with permission from email correspondence with Dr. Devere.) 

So, please, doctors ... if caregivers share worrisome symptoms of possible dementia with you, listen to them carefully.  They just may do a better job of presenting you with patients’ symptoms of dementia than any cognitive screening test will reveal.

Originally titled, "Doctors ... Please Listen to Alzheimer's Caregivers."  Published in The Journal of Family Practice,  May, 2011, Vol. 60, No. 05, p. 250.  Access at:
http://www.jfponline.com/index.php?id=21643&cHash=071010&tx_ttnews(tt_news)=175994


 



Saturday, August 10, 2013

Alzheimer's and Baby Boomers


My wife has Alzheimer’s Disease (AD).  Only 63 when diagnosed last year, my wife is technically classified as having EOAD ... Early Onset Alzheimer’s Disease ... a tag given to those who are diagnosed before the age of 65.  According to the Alzheimer’s Association, 5.3 million people in this country currently have AD and 200,000 are younger the age of 65.  What is really scary is that with 10,000 baby boomers turning 65 each day starting next year, and with no cure currently in sight, some health experts have estimated that we may have as many as 16 million people suffering from AD by 2050.  The medical profession, and helping organizations such as the Alzheimer’s Association, must change some current practices to deal more effectively with the growing number of ‘‘boomer patients’’ they are soon going to see.

The Alzheimer’s Association currently provides many day care activity programs for those with moderate to severe stages of AD, and that is a good thing.  However, there is virtually no support available to those with EOAD or for those in the earliest stages of AD.  As but one example, here on Long Island, NY, where the Alzheimer’s Association estimates that there are 55,000 people with AD, they currently offer 35 groups for spouses and/or caregivers and many day care program opportunities for those with AD.  However, they provide no support groups for people with AD.  Not one.  This is pretty much true for the entire country ... many activity groups but few support groups for those with AD.  One explanation given to me is that people with EOAD and early stage AD often do not want to talk about their feelings with others ... they find it too depressing. And that may well be true.  However, what about those in early stages or with EOAD who do want to talk with others in similar circumstances?  Shouldn’t there be at least a few support groups led by trained social workers available to them?

Fortunately, here on Long Island we also have LIAF, the Long Island Alzheimer’s Foundation, which does have groups for those in early to moderate stages of AD and a separate group for their spouses/caregivers.  My wife and I attend these weekly meetings and find them very helpful.  But not even LIAF has a group solely for those with EOAD or for spouses of those with EOAD.

As is true for each successive generation, we boomers are quite different from our parents in many ways.  Having grown up with computers and the internet, many of us are quite knowledgeable about AD through online sources of information, and some of us, at least, would like to meet with others in similar situations.  Unfortunately, presently throughout much of this country, there are no such opportunities. This must change. 

The medical profession must also change. As is true for many eventually diagnosed with AD, my wife began exhibiting AD symptoms for several years before the official diagnosis was made.  I told doctors about her worsening symptoms at each visit, but my comments were routinely ignored.  I noted how she kept asking me the same question over and over without any recollection of having just asked me that same question minutes earlier.  I mentioned her getting lost while driving in our community, her disorientation, her aphasia.  I said that my wife was forgetting how to do things she used to do routinely, and how she was regularly misplacing and losing objects at home and when we traveled.  However, her initial cognitive testing results were good, MRIs and blood work did not show any problems, and doctors suggested that the symptoms I described were probably due to stress, and then later to anxiety.  When cognitive testing results worsened later on, the diagnosis became severe cognitive impairment due to depression.  I continued to note that her symptoms were not related to stress or depression according to any website I had consulted, but my comments were routinely ignored.  After continued worsening of her symptoms, we eventually went for a second opinion at a hospital-affiliated Alzheimer’s Disease Research Center where the diagnosis was probable AD ... and definitely not stress, anxiety, or depression.

I’ll be the first to admit that some of the early signs of AD are identical to signs of stress and/or depression.  A doctor who diagnoses stress or depression as the cause of memory disorders can offer hope to patients.  Anti-depressant medications and stress-reduction techniques may often lead to improvement. However, a doctor who diagnoses probable AD gives patients a death sentence because AD is a terminal disease with no cure, and the average person diagnosed with AD lives for only 8 years.  I wonder whether some neurologists and cognitive psychologists think, why not treat the problem as if it were stress or depression since we may be able to help the patient improve; if I diagnose AD, then there is no hope for improvement.

Many AD spouses I have contacted across the country on websites devoted specifically to spouses of those with AD have, sadly, reported identical experiences with their doctors.  So many reported that their observations were also ignored that I must conclude that this may be common practice ... doctors basing their diagnosis and treatment recommendations solely on objective testing results after relatively brief visits with patients, largely disregarding anecdotal observations of spouses and caregivers.  This needs to change!  Empirical data from cognitive testing and medical procedures are very important but so are anecdotal and observational data from spouses and caregivers who observe noticeable changes in the patient’s daily life.  Empowered by information readily available on the internet, baby boomers may have valuable insights to offer doctors about their loved one’s symptoms that may not be apparent in brief office visits or demonstrated on objective tests of memory.

Alzheimer’s Disease takes a terrible toll on those suffering from the disease and on their spouses/caregivers.  Doctors must listen more carefully to symptoms of patients reported by their spouses/caregivers so those with probable AD are diagnosed early and can begin taking medications that may help slow the inevitable degenerative progression.  Doctors as well as local/ national AD organizations should also be working together to provide patients with ready access to support groups as patients progress though the stages of this fatal disease ... and helping to better meet the needs of those who are diagnosed at a young age and/or are in the very early stages of the disease.

Published in American Journal of Alzheimer's Disease & Other Dementias, September, 2010, Vol. 25, No. 6, pp.477-478.  Access at:
http://aja.sagepu.com/content/26/2/93.full.pdf+html

Ten Things You Should Do When the Diagnosis is Alzheimer's

Alzheimer's Disease (AD) is, admittedly, sometimes tricky to diagnose.  Since a positive diagnosis can only be made post mortem upon examination of the ‘plaques and tangles‘ and deterioration/shrinkage of the brain, diagnoses of AD are often issued with the caveat, ‘probable’ AD.  However, for patients diagnosed with ‘probable’ AD and their caregiver spouses, such diagnoses are not probable ... they are very real. And those diagnoses are rising in record numbers as baby boomers age.  An estimated 5.3 million people in the U.S. already have AD, with those numbers expected to double in the next 20 years.  This year alone, global costs of dementia are expected to exceed 1% of world GDP for a staggering total of $601 billion dollars, with more than half of that number solely due to Alzheimer's, the most common form of dementia.

Primary care physicians, internists, neurologists, psychologists, and psychiatrists are all doctors who may make probable AD diagnoses for their patients.  I am the spouse/caregiver of an AD patient.  My wife wasn't diagnosed with AD until age 63,
but she had been demonstrating many AD symptoms by age 61. For two years, however, those symptoms had been incorrectly attributed to stress, anxiety, or depression.  It is obvious to spouse/caregivers in my weekly and online support groups that doctors can and should be doing a better job of diagnosing AD sooner ... and a much better job of providing their patients and spouses with a lot more information at the time of diagnosis.  Here's a "Top Ten" list of things that I and most caregivers I know wish doctors would do when issuing a diagnosis of AD.

1.  Do not use only objective data to try to make a correct diagnosis.
Members of my support group literally laugh out loud when someone brings up the MMSE (Mini-Mental State Examination), perhaps the most widely used measure to help diagnose Alzheimer's.  Doctors should understand that this test, and others like it, measure only selective elements of memory and cognition.  Some AD patients will do relatively well on these tests on any given day even when that patient's ability to function in the ‘real world‘ is continuing to decline.  Answers to questions such as what day of the week it is, what is today's date, etc. may simply be dependent upon whether or not the patient watched the TV news that morning or looked at that day's newspaper in the office.  Patients may be able to recall a series of random numbers in sequence on a particularly good day yet be unable to recall their own phone number or date of birth.  On a ‘good day’ a patient may be able to spell the word ‘world’ backwards yet be aphasic during conversations at home.  Objective test results will vary day to day and should be, at best, only one very limited measure used to reach a proper diagnosis.

2.  Rely more upon the observations of spouses or significant others.
If you live with someone 24/7, you know  when something is wrong with your wife or husband.  More often than not, it is a worried spouse or significant other who first brings AD concerns to the doctor's attention.  More often than not, it is the worried spouse insisting upon a thorough examination of their husband or wife due to fears of probable AD.  Doctors should not dismiss these concerns lightly.  Many spouses/significant others also keep logs or journals to document their concerns for doctors, but if the doctors do not see similar symptoms themselves during their brief office visits, these concerns are often ignored.  It is the rare AD patient whose spouse/significant other hasn't seen multiple signs of AD for a long period of time prior to any official medical diagnosis.  Doctors should ask more questions of spouses/significant others and listen to what they have to say.

3.  If not an expert in AD, refer your patient to a doctor who is an expert.
Often it is the family primary care physician or internist who is the first to suspect a change in their patient's condition or the first to be approached by the patient or spouse with concerns.  If in unfamiliar territory, the PCP or internist should refer patients to a neurologist or geriatric psychiatrist with experience diagnosing and treating AD patients.  In some geographical locations, a referral to a nearby Memory Disorder Clinic or Alzheimer's Disease Research Center would be worthwhile.  Too often, it seems, a PCP/internist may correctly diagnose the patient but then give incorrect or incomplete information due to lack of awareness.  Or, worse, a PCP/internist may suggest that a patient has MCI, Mild Cognitive Impairment, thereby relieving the concerns of the patient and/or caregiver who had worried about a probable AD diagnosis without then continuing to explain that, for many people, MCI is simply the first stage of Alzheimer's ... and, for many others, MCI will eventually lead to AD.

4.  Understand that no two patients with AD react exactly the same.
We have an expression in my support groups:  “If you know one person with Alzheimer's, then you know one person with Alzheimer‘s."  Each caregiver can provide a different description of exactly what is happening to their spouse.  Are there similarities?   Of course ... there are many.  But many does not equate to all.  And, just as important, patients with AD do not all decline in the same manner.  Some stabilize at certain stages for long periods of time before conditions worsen.  Some suffer slow incremental declines whereby symptoms continually worsen gradually over time.  Others follow what I refer to as a ‘cliff fall/plateau' pattern.  They seem to ‘fall off a cliff‘ every few months with a significant worsening of one or more symptoms, then reach a plateau where the decline stops for several months, and then seem to fall off another cliff.  And still others seem to manifest combinations of patterns of decline at different times.  Doctors should explain these different patterns to their recently diagnosed patients, and their spouses, so they may be better prepared for what may come their way.

5.  Explain that we currently do not know how to effectively treat AD.
Although some may disagree and suggest that being too honest with a diagnosis will send some caregivers and/or patients into increased denial and/or result in feelings of total despair, I firmly believe that patients and caregivers are entitled to know just what they are dealing with ... despite the lack of an optimistic future.  Be honest with patients about this disease.  Explain that AD is a degenerative, fatal disease for which there is no cure.  Explain that as a terminal disease, the patient will not get better over time and symptoms will continue to worsen regardless of any treatment they undertake. Also explain that all current research indicates that remaining mentally active, improving one's diet, engaging in daily physical exercise, and a whole host of other activities may improve the quality of life and even reduce chances of heart or vascular disease ... but none of these interventions will stop the worsening progression of AD.  Explain that for some patients, medication will not do anything to help, but for some they may slow down the rate of cognitive decline for 6 months, a year, maybe two years at best.  Explain, however, that after that period of time, even if they had been effective in slowing the progress of this disease to that point, they will no longer be effective and the patient will continue to suffer cognitive decline whether still taking those medications or not.  I have started referring to all medications designed for Ad patients as having the same label ... Hope.  Doctors continue to prescribe them, and patients continue to take them, long after they can possibly still be effective.  Why?  Because doctors and patients hope that, in their individual case, the medication will work despite what the research shows.  Even when the cost of that medication results in financial hardship, many patients will continue taking ineffective medication because they hope that is better than taking nothing.

6.  Inform your patients about clinical trials.
If your patient lives in an area where there are clinical trials underway testing the efficacy of potential new treatments for AD, inform your patients and their spouses of how they can learn more about those trials.  If you are knowledgeable about one or more trials, feel free to explain why you think a particular trial might be worth considering.  But at the very least, please inform your patients and their spouses about the existence of such clinical trials.

7.  When the AD diagnosis is made, tell your patients not to drive anymore.
In a handful of states, physicians are required to report the names of patients diagnosed with probable AD to the Department of Motor Vehicles.  The DMV is then responsible for re-assessing that person's ability to continue driving.  Currently, the vast majority of patients diagnosed with AD continue to drive.  I think that a diagnosis of AD should mandate removal of a driver's license within a reasonable period of time, 3-6 months at most.  I disagree with the Alzheimer's Association, the American Academy of Neurology, and other organizations that feel that the decision of whether or not to continue driving should be left to the patient.  Wrong!   Why do I say this? Simply because we know that anyone diagnosed with AD already has, or will have, impaired judgment and reasoning skills that affect safe driving.  Multiple decisions and processing skills are in play each time someone gets behind the wheel of a weapon of limited destruction, which is what an automobile really is. Impaired drivers may still easily pass their driving test on any given day.  However, doctors know that at some point these same AD-impaired drivers who are passing these tests will suffer declining skills that will prevent their ability to drive safely.  It is not a question of if this will happen ... the only question is when this will happen.

Why must we wait for a person with AD to damage his/her automobile or that of another, cause property damage to an innocent person, injure him/ herself or others in an accident, or possibly cause the death of others, or possibly get lost while driving when all of these occurrences are easily preventable before they happen?  Without a doubt, when to take away the keys from someone recently diagnosed with Alzheimer's is often the single most difficult decision to be made.  This signals an awareness of disease and a loss of independence; it may have severe implications on that person's ability to continue working or continued enjoyment of retirement.  And that is why I suggest a period of 3-6 months be provided for that recently diagnosed patient to come to grips with his/her new reality and time to make plans to deal with the situation  perhaps arranging for someone else to drive that person to/from work or making some other alternate plans for transportation.  If we know that a person diagnosed with AD is going to decline more over time, why not admit the obvious?  And the obvious is that someone diagnosed with Alzheimer's simply should not be behind the wheel of a moving vehicle. In my support groups, we often suggest to ‘newbies’ who are first dealing with this new reality, “Would you feel comfortable with your grandchildren in the car while your AD spouse is driving?"

Too often one hears in support groups how caregivers implore their AD spouses to stop driving because they have observed firsthand that their spouse is no longer driving safely.  However, their AD spouse will often respond, “But the doctor never said I had to stop driving."  Please, doctors, take this very emotional and combative issue out of the hands of spouses.  Take responsibility for telling your AD patients that they must stop driving!

8.  Upon diagnosis, refer your patient and spouse to local support groups.
Sadly, support groups are not uniformly provided throughout this country.  Some cities and some states have local and state associations that provide a multitude of support groups for both the patients, their spouse/caregivers, and for non-spouse caregivers, often through branches of the Alzheimer's Association, the Alzheimer's Foundation, or hospitals.   If there are such groups near where your patient and spouse live, please refer them to those groups or organizations.  And if not, please consider speaking with leaders of your state's associations to have such groups formed.  Also, become aware of the excellent online support groups available that you can recommend. Spouses can go to such places as www.thealzheimerspouse.com for information and chat rooms, or to sites such as www.mayoclinic.com for a wealth of AD information and a blog site for reading and posting comments.

9.  Upon diagnosis, refer your patient’s spouse/caregiver to print resources.
Eventually, over time, all spouses learn about some good books that they should read to gain insights into this horrible disease.  Good books, like a good support group, will inform and empower spouses/caregivers.  Too often, spouses/caregivers say, “I wish someone had told me about that sooner when my spouse was still in the early stages so I could have prepared myself for the " ____________.”  (One can fill in the blank with so many choices ... difficulties when traveling, incontinence, wandering, raging, etc.)  If you are unfamiliar with good books to recommend, then at the very least prepare a one or two page informational handout to give to your patients at the time of diagnosis.  This handout can also list several websites such as those noted above, and phone numbers of local organizations ... branch offices of the Alzheimer's Association and the Alzheimer's Foundation, for example ... that can provide patients/caregivers with additional information about the disease, support groups if available, and suggested books to read.

10. Tell your patient and spouse/caregiver what they need to know sooner.
If there is one message that must get through to doctors above all others, it is this:  It is extremely important for the doctor to tell both the patient and the spouse/caregiver not what they may want to hear, but what they need to know.  Doctors must be brutally honest when discussing the progression of likely AD symptoms so patients and their spouses/caregivers will know what to expect.  Providing false hope that medications or life style changes or anything else will prevent certain death is disingenuous.  Doctors must present the scenario of symptoms and behaviors that most, if not all, AD patients will experience as their disease progresses through mild, moderate, and severe stages.  Doctors should explain that whereas the progress of AD after diagnosis can be as fast as four years and as long as twenty years, the average person with AD only lives for eight to ten years after diagnosis.  Doctors should explain how important it is for spouses to discuss end-of-life plans now, while the AD patient is still generally able to process rational thought.  Doctors should suggest that the patient and spouse seek out an eldercare attorney who can help them with decisions that must be made with respect to having a current will, living will and health care proxy, and durable power of attorney.  Doctors should suggest that their patient and spouse begin having discussions on how/where/when to provide assistance as the  disease worsens.  Should care be provided at home with hourly or full time health care aides?  In an assisted living facility?  In a nursing home?  An eldercare attorney will also discuss financial ramifications of such choices and suggest other options, but the doctor should get the ball rolling on end-of-life decisions and care because traumatized patients and spouses may not understand that this is something that needs their attention sooner rather than later.

Some doctors, I'm sure, will suggest that to hold these  discussions as soon as the patient is diagnosed is TMI ... Too Much Information.  And I agree.  The diagnosis may not be well received by either the patient and/or the spouse, resulting in reactions ranging from anger and shock to disbelief and denial.  However, I am suggesting that this information be provided in a follow-up visit no more than 2-4 weeks after diagnosis, once the patient and spouse/caregiver have had a chance to absorb hearing the words, Alzheimer’s Disease, and the bleak prognosis.  Waiting longer is a disservice to both patient and spouse/caregiver because information on stages of this disease, medications, clinical trials, driving, support groups, helpful books and resources are most helpful if provided sooner rather than later.

Alzheimer's is a horrible journey not just for the patient ... it's also horrible for the spouse/caregiver.  Doctors can make the journey so much easier for patients and spouses if they would heed This ‘Top Ten‘ list. Do you want to leave your patients and their caregivers with some hope when they leave your office after such a horrible diagnosis?  Of course you do.  Do you want to maintain a relationship with your patients/caregivers after diagnosis?  Of course you do.  However, just like a good marriage must be based on trust, so too must a doctor/patient/caregiver relationship be based upon trust.  If you feel my ‘brutally honest approach’ will backfire with respect to your patient and the patient's spouse/caregiver in their efforts to seek out the help they need to get through this disease, then perhaps you may need to cover this information during the course of several visits over a period of several weeks or months.  But, please, do cover it all because to do less is not just disingenuous.  To do less is to give your patients and their spouses/ caregivers false hope.  And that, in my opinion, is worse than no hope at all.  So, doctors ... please ... act upon some of these suggestions for dealing with your AD patients and their spouses.  Thank you.
 
Originally submitted titled, "An Open Letter to Doctors, Ten Things ..."  Published in American Journal of Alzheimer’s Disease & Other Dementias, March, 2011, Vol. 26, No. 2, pp. 93-96.  Access at:  http://aja.sagepub.com/content/26/2/93.full.pdf+html